Breast cancer mortality in African-American and non-hispanic white women by molecular subtype and stage at diagnosis: A population-based study

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 7, 2015, Pages 1039-1045

  Tao, Li ^a   Gomez, Scarlett Lin ^a,b   Keegan, Theresa H M ^a,b   Kurian, Allison W ^b   Clarke, Christina A ^a,b  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CAUCASIAN; CAUSE OF DEATH; CLINICAL EVALUATION; DEMOGRAPHY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULAR DIAGNOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; SOCIAL STATUS; TRIPLE NEGATIVE BREAST CANCER; AGE; BREAST NEOPLASMS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH SURVEY; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURVIVAL RATE; TRENDS; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84939260645     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.epi-15-0243     Document Type: Article

References (59)

1. Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007;25:1683-90.
2. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005;294:1765-72.
3. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Fay MP, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975- 2000, National Cancer Institute. Bethesda, MD; 2003. Available from: http://seer.cancer.gov/csr/1975-2000/.
4. Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat 2005;92:97-105.
5. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006; 56:168-83.
6. Maskarinec G, Sen C, Koga K, Conroy SM. Ethnic differences in breast cancer survival: status and determinants. Womens Health 2011;7:677-87.
7. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-502.
8. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 2011;127: 729-38.
9. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-48.
10. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, et al. Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 2013;310:389-97.
11. Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 1996;78:1395-402.
12. Jones BA, Dailey A, Calvocoressi L, Reams K, Kasl SV, Lee C, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screeningmammography process study (United States). Cancer Causes Control 2005;16:809-21.
13. Gerend MA, Pai M. Social determinants of Black-White disparities in breast cancer mortality: A review. Cancer Epidemiol Biomarkers Prev 2008;17: 2913-23.
14. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Metaanalysis of survival in African American and white American patients with breast cancer: Ethnicity compared with socioeconomic status. J Clin Oncol 2006;24:1342-9.
15. Beverly LN, Flanders WD, Go RC, Soong SJ. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health 1987;77:351-3.
16. Newman LA. Breast cancer in African-American women. Oncologist 2005;10:1-14.
17. Bernstein L, Lacey JV Jr. Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? J Natl Cancer Inst 2011;103:451-3.
18. Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer 2013; 13:225.
19. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, et al. Race and triple negative threats to breast cancer survival: A populationbased study in Atlanta, GA. Breast Cancer Res Treat 2009;113:357-70.
20. Sachdev JC, Ahmed S, Mirza MM, Farooq A, Kronish L, Jahanzeb M. Does race affect outcomes in triple negative breast cancer? Breast Cancer (Auckl) 2010;4:23-33.
21. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-11.
22. Yang J, Schupp CW, Harrati A, Clarke C, Keegan THM, Gomez SL. Developing an area-based socioeconomic measure from American Community Survey data. Cancer Prevention Institute of California, Fremont, California 2014. Available at http://www.cpic.org/cancer-registry/cancersurveillance/acs-ses-report.aspx.
23. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry. Cancer 2007;109:1721-8.
24. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25:118-45.
25. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-52.
26. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-6.
27. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 2002;94:471-3.
28. Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer 2000;88:1256-64.
29. Parise CA, Caggiano V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. BMC Cancer 2013;13:449.
30. O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010;16:6100-10.
31. Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, et al. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 2004;101:1293-301.
32. Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, et al. Genomewide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat 2011;127:297-308.
33. Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS ONE 2012;7:e37928.
34. Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, et al. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 2009;4:e4531.
35. Anders C, Carey LA. Understanding and treating triple-negative breast cancer. Oncology 2008;22:1233-9; discussion 9-40, 43.
36. Alvarez RH, Valero V, Hortobagyi GN. Emerging targeted therapies for breast cancer. J Clin Oncol 2010;28:3366-79.
37. Hudis CA, Gianni L. Triple-negative breast cancer: An unmetmedical need. Oncologist 2011;16 Suppl 1:1-11.
38. Livaudais JC, Li C, John EM, Terry MB, Daly M, Buys SS, et al. Racial and ethnic differences in adjuvant hormonal therapy use. J Womens Health 2012;21:950-8.
39. Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, et al. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev 2013;22:365-73.
40. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006;24:1357-62.
41. Dignam JJ. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr 2001;30:36-43.
42. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 2003;81:21-31.
43. Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, et al. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat 2013;137:247-60.
44. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: An HMO and fee-for-service comparison. JAMA 1999;281:720-6.
45. Mandelblatt JS, Kerner JF, Hadley J, Hwang YT, Eggert L, Johnson LE, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer 2002;95:1401-14.
46. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 2002;94:666-8.
47. American Cancer Society. Cancer Facts and Figures for African Americans 2011-2012. Atlanta, GA: American Cancer Society; 2011.
48. Greenwald HP, O'Keefe S, Dicamillo M. The importance of public sector health care in an underserved population. J Health Hum Serv Adm 2004;27:142-57.
49. Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008;58:9-31.
50. Moore KA. Breast cancer patients' out-of-pocket expenses. Cancer Nurs 1999;22:389-96.
51. Chirikos TN, Russell-Jacobs A, Jacobsen PB. Functional impairment and the economic consequences of female breast cancer. Women Health 2002;36:1-20.
52. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breastconserving surgery. J Natl Cancer Inst 2000;92:269-71.
53. Lamont EB, Hayreh D, Pickett KE, Dignam JJ, ListMA, Stenson KM, et al. Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst 2003;95:1370-5.
54. Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 2004;22:3685-93.
55. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998;279:1801-7.
56. Lannin DR, Mathews HF, Mitchell J, Swanson MS. Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg 2002;184:418-23.
57. LaVeist TA, Carroll T. Race of physician and satisfaction with care among African-American patients. J Natl Med Assoc 2002;94:937-43.
58. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-10.
59. Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: A population-based analysis. J Natl Cancer Inst 2009;101:993-1000.